Pain Management with Morphine
Introduction to Morphine Administration
- Subcutaneous morphine is preferred over intramuscular morphine for pain management due to its simpler administration, reduced pain at injection site, and equivalent efficacy with fewer complications 1
- The British Journal of Cancer evidence strongly recommends against intramuscular morphine for chronic cancer pain management due to several important reasons, including requiring a smaller needle, lower risk of nerve damage, and less painful for patients 1
Advantages of Subcutaneous Administration
- Subcutaneous administration has advantages over intramuscular, including a lower risk of nerve damage, injection site is less crucial, reduced risk of inadvertent intravenous injection, and simpler to administer 1
- Subcutaneous administration provides similar absorption profiles and efficacy to intramuscular administration, with peak plasma concentrations achieved within 15-30 minutes and equivalent analgesic efficacy 1
Converting to Parenteral Morphine
- When converting from oral to parenteral morphine, the average relative potency ratio of oral morphine to subcutaneous morphine is between 1:2 and 1:3, and the oral dose should be divided by three to achieve equianalgesic effect 1
- Subsequent dose adjustments may be needed based on individual response when converting from oral to subcutaneous morphine 1
Preferred Methods of Administration
- For patients requiring continuous parenteral morphine, subcutaneous infusion via portable battery-operated syringe drivers is the preferred method, allowing for continuous slow infusion for patients unable to take oral medication 1
- Intravenous administration may be preferred over subcutaneous in specific circumstances, such as patients with existing intravenous lines, generalized edema, or coagulation disorders 1